Saturday, 5 September 2026European Markets
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 16, 2026

Taiwan Semi raises 2026 outlook after Q1 profit surges amid AI demand

View original at seekingalpha.com
“in Q1, we saw an expansion from ~58% in GP margin to over 66%, which is insanely solid for such a large entity”
Verbatim excerpt from the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Initial ramp-up of 2nm technology will start to dilute gross margin in H2 2026 with expected 2-3% dilution for full year 2026

    60% confidence
  • Q1 earnings solid with gross and operating margins above guidance; Q2 guidance above expectations with continued margin expansion; TSMC confident in market share; lack of meaningful revenue and capex upside may be mild disappointment but estimates likely to move up over next 2-3 quarters

    60% confidence
  • TSMC saw gross margin expansion from ~58% to over 66% in Q1, showing major pricing power and superior execution, with business mix shifting toward higher-value products; rates stock a buy after the print

    60% confidence
  • TSMC does not expect any near-term impact on operations for material supply and works closely with Taipower and Taiwan government to ensure stable and sufficient energy supply

    60% confidence
  • Raised 2026 sales guidance and capex guidance is a positive surprise; stronger conviction reflects stronger-for-longer Cloud AI demand and requirement to speed-up capacity expansion

    60% confidence
  • With another strong quarter, stronger Q2 forecast, and competitive risk seemingly years away, Wedbush sees no reason to shift constructive view on TSMC

    60% confidence
  • AI-related demand continues to be extremely robust

    60% confidence
  • Given the recent situation in the Middle East, prices for certain chemicals and gases are likely to increase, which may impact profitability but it is too early to quantify

    60% confidence
  • TSMC forecasts gross margin dilution from overseas fab ramp-up to be 2-3% in early stages and widen to 3-4% in latter stages

    60% confidence
  • Moving into second quarter 2026, business expected to be supported by continued strong demand for leading-edge process technologies

    60% confidence
  • Our business in the first quarter was supported by strong demand for our leading-edge process technologies

    60% confidence
  • Best highlight is 66.2% GM reported for Q1 2026 and 66.5% GM guided for Q2 2026; AI demand outlook remains robust; TSMC trying to balance customer demand and avoiding CapEx overrun; history shows betting on TSMC margin compression has negative risk/reward

    60% confidence
  • Historically, TSMC does not add additional capacity to a node once it has reached its target capacity, but is stepping up CapEx investment to increase N3 capacity to meet strong demand in AI application

    60% confidence
  • At TSMC, a higher level of capital expenditures is always correlated with higher growth opportunities in the following years

    60% confidence
  • TSMC remains committed to a sustainable and steadily increasing cash dividend per share on both an annual and quarterly basis

    60% confidence

Data points we hold from this source

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
Taiwan Semi raises 2026 outlook after Q1 profit surges amid AI demand — Source | Via News | ViaNews EU